Centro Oncologico Rosario

Rosario S2000DSK

0 studies enrolling now · 2 studies all time

What they study most

Hormone Refractory Prostate Cancer, Non-small Cell Lung Cancer, Prostate Cancer

Studies at this site

• Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment — Completed
• Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen — Completed